Avanos Medical (AVNS) Fundamental Analysis: Revenue, Earnings & Valuation

8.26 / 10

Outperform

Fundamental metrics indicate superior status (8.3/10). Bullish considerations: Profit-MV and Net cash flow from operating activities / Operating revenue (%), balanced by issues in Net income-Revenue and Revenue-MV. Final rating: highly favorable.

Analysis Checks(8/10)

Revenue-MV

Value0.80

Score1/3

Weight-7.54%

1M Return-1.53%

ROA (%)

Value-6.54

Score2/3

Weight1.39%

1M Return0.26%

Net cash flow from operating activities / Operating revenue (%)

Value10.65

Score3/3

Weight8.87%

1M Return1.44%

Profit-MV

Value0.62

Score2/3

Weight6.38%

1M Return1.09%

Net income-Revenue

Value-0.05

Score1/3

Weight-13.20%

1M Return-2.75%

Total profit / EBIT (%)

Value107.47

Score3/3

Weight9.85%

1M Return1.68%

Annualized net profit margin on total assets (%)

Value-6.54

Score2/3

Weight1.39%

1M Return0.26%

EBIT / Total operating revenue (%)

Value-8.78

Score3/3

Weight9.06%

1M Return1.51%

Asset-MV

Value-0.72

Score3/3

Weight53.76%

1M Return8.17%

Cash-MV

Value0.38

Score3/3

Weight30.02%

1M Return4.70%

Is AVNS undervalued or overvalued?

AVNS scores 8.26/10 on fundamentals and holds a Discounted valuation at present. Backed by its -9.07% ROE, -10.40% net margin, -8.90 P/E ratio, 0.83 P/B ratio, and 81.59% earnings growth, these metrics solidify its Outperform investment rating.